Neurological abnormalities in a knock-in mouse model of Huntington's disease
- PMID: 11152661
- DOI: 10.1093/hmg/10.2.137
Neurological abnormalities in a knock-in mouse model of Huntington's disease
Abstract
Mice representing precise genetic replicas of Huntington's disease (HD) were made using gene targeting to replace the short CAG repeat of the mouse Huntington's disease gene homolog (HDH:) with CAG repeats within the length range found to cause HD in humans. Mice with alleles of approximately 150 units in length exhibit late-onset behavioral and neuroanatomic abnormalities consistent with HD. These symptoms include a motor task deficit, gait abnormalities, reactive gliosis and the formation of neuronal intranuclear inclusions predominating in the striatum. This model differs from previously described HDH: knock-ins by its method of construction, longer repeat length and more severe phenotype. To our knowledge, this is the first knock-in mouse model of HD to show increased glial fibrillary acidic protein immunoreactivity in the striatum, suggesting that these mice have neuronal injury similar to that found early in the course of HD. These mice will serve as useful reagents in experiments designed to reveal the molecular nature of neuronal dysfunction underlying HD.
Similar articles
-
Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45. doi: 10.1098/rstb.1999.0456. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434303 Free PMC article.
-
Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.J Comp Neurol. 2003 Oct 6;465(1):11-26. doi: 10.1002/cne.10776. J Comp Neurol. 2003. PMID: 12926013
-
Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice.Hum Mol Genet. 2006 Jun 15;15(12):2015-24. doi: 10.1093/hmg/ddl125. Epub 2006 May 10. Hum Mol Genet. 2006. PMID: 16687439
-
Polyglutamine pathogenesis.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1005-11. doi: 10.1098/rstb.1999.0452. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434299 Free PMC article. Review.
-
The use of transgenic and knock-in mice to study Huntington's disease.Cytogenet Genome Res. 2003;100(1-4):276-86. doi: 10.1159/000072863. Cytogenet Genome Res. 2003. PMID: 14526189 Review.
Cited by
-
A Longitudinal Motor Characterisation of the HdhQ111 Mouse Model of Huntington's Disease.J Huntingtons Dis. 2016 May 31;5(2):149-61. doi: 10.3233/JHD-160191. J Huntingtons Dis. 2016. PMID: 27258586 Free PMC article.
-
Onset and progression of behavioral and molecular phenotypes in a novel congenic R6/2 line exhibiting intergenerational CAG repeat stability.PLoS One. 2011;6(12):e28409. doi: 10.1371/journal.pone.0028409. Epub 2011 Dec 7. PLoS One. 2011. PMID: 22163300 Free PMC article.
-
Longitudinal in vivo MRI in a Huntington's disease mouse model: Global atrophy in the absence of white matter microstructural damage.Sci Rep. 2016 Sep 1;6:32423. doi: 10.1038/srep32423. Sci Rep. 2016. PMID: 27581950 Free PMC article.
-
Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease.bioRxiv [Preprint]. 2023 Dec 18:2023.12.18.572239. doi: 10.1101/2023.12.18.572239. bioRxiv. 2023. PMID: 38187773 Free PMC article. Preprint.
-
Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation.Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13135-40. doi: 10.1073/pnas.0505801102. Epub 2005 Sep 2. Proc Natl Acad Sci U S A. 2005. PMID: 16141322 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases